| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-052 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2017-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fcfe9f61a1548d8c22a1586d738c672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45520d0787936e6b3e448c68c4c290f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce4bd4bf55aef1478a6377bf16ad79ff |
| publicationDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017202912-A1 |
| titleOfInvention |
Optogenetic control of inputs to the ventral tegmental area |
| abstract |
The present disclosure provides a method of inducing or modulating reward- or aversive-related behaviors in animals using light-responsive opsins. The present disclosure provides methods of identifying or screening compounds that may be used to treating mental disorders, or are relevant to disrupt or improve reward- or aversive related behaviors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10350430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10371776-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10627410-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9969783-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10087223-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11294165-B2 |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |